Crossed Leg Sign and it's Correlation With Significant Pathology

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2012 by Uelk, J. Daniel, D.O..
Recruitment status was Not yet recruiting

Sponsor:

Information provided by (Responsible Party):

Uelk, J. Daniel, D.O.

ClinicalTrials.gov Identifier:

NCT01569542

First received: March 30, 2012

Last updated: NA

Last verified: March 2012

History: No changes posted

Purpose

By determining the correlation of a Crossed Leg Sign with significant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.

Condition
Pathology


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Crossed Leg Sign and it's Correlation With Significant Pathology

Further study details as provided by Uelk, J. Daniel, D.O.:


Estimated Enrollment:	400
Study Start Date:	May 2012
Estimated Study Completion Date:	February 2013
Estimated Primary Completion Date:	February 2013 (Final data collection date for primary outcome measure)

Detailed Description:

By determining the correlation of a Crossed Leg Sign with significant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology. Therefore, by determining the sensitivity and specificity of this physical exam finding, the clinician would have a better idea of the patients clinical management, including diagnostic testing and ultimate treatment of the patient. Crossed Leg Sign will be defined in this study as: any patient observed in the Emergency Department with sustained crossed legs. To my knowledge, crossed legs have never been evaluated in regards to it's correlation with significant pathology. This could potentially add another physical exam finding to be used by the clinician.

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

This study should include all comers. To exclude a patient population would add a selection bias.

Criteria

Inclusion Criteria:

Any patient observed in the Emergency Department with sustained crossed legs.

Exclusion Criteria:

Any patient not observed to have sustained crossed legs and is not being used as a control.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01569542

Contacts


Contact: John D Uelk, DO	314-605-4486	juelk1@hfhs.org
Contact: Michael Ward, DO	908-930-2405	mward4@hfhs.org

Locations


United States, Michigan
Henry Ford Wyandotte Hospital	Not yet recruiting
Wyandotte, Michigan, United States, 48192
Contact: John D Uelk, DO 314-605-4486 juelk1@hfhs.org
Principal Investigator: John D Uelk, DO

Sponsors and Collaborators

Uelk, J. Daniel, D.O.

Investigators


Principal Investigator:	John D Uelk, DO	Henry Ford Health System

More Information


Responsible Party:	Uelk, J. Daniel, D.O.
ClinicalTrials.gov Identifier:	NCT01569542 History of Changes
Other Study ID Numbers:	John Daniel Uelk Henry Ford Wyandotte Hospital
Study First Received:	March 30, 2012
Last Updated:	March 30, 2012
Health Authority:	United States: Federal Government

ClinicalTrials.gov processed this record on September 23, 2016

To Top